Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Prostaglandin derivative DE-085 increases retinal blood flow

May 6, 2004

St. John's wort and hypericin may prevent diabetic and premature retinopathy

May 6, 2004

Specific cannabinoid receptor agonist may prevent tissue damage in retina

May 5, 2004

Tyrosine kinase inhibitor blocks choroidal neovascularization

May 4, 2004

Regression of ocular neovascularization by periocular PEDF gene therapy

May 4, 2004

CpG ODN 1826 activates uveitogenic T-cells in mice

May 4, 2004

Promising topical ciclosporin prodrug against corneal graft rejection

May 3, 2004

PKC-412 improves retinal volume and visual acuity in DME patients

May 3, 2004

Vaccines suggested as an alternative for treating glaucoma

April 30, 2004

Adjunctive therapy with lerdelimumab after phacotrabeculectomy beneficial for IOP

April 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...